3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Uterine Cervical Neoplasms
2
Ovarian Neoplasms
2
Skin Neoplasms
1
Peritoneal Diseases
1
Ovarian Diseases
1
Neoplasms
1
Neoplasm Metastasis
1
Fallopian Tube Neoplasms
1
Fallopian Tube Diseases
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
6
Paclitaxel
6
Magnetic Resonance Spectroscopy
5
Nivolumab
4
Carboplatin
4
Biopsy
4
pembrolizumab
2
olaparib
2
ceralasertib
2
Taxes
2
trastuzumab deruxtecan
1
sargramostim
1
rucaparib
1
ribociclib
1
rebastinib
1
pelcitoclax
1
pamiparib
1
durvalumab
1
cobimetinib
1
cediranib
1
cabozantinib
1
belinostat
1
atezolizumab
1
X-Rays
1
Tissue Banks
1
TIC10 compound
1
Ipilimumab
1
Immunoglobulin G
1
Ifosfamide
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Tissue Banks
×
Gynecologic
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled